Literature DB >> 11146703

Assessing clinical probability of pulmonary embolism in the emergency ward: a simple score.

J Wicki1, T V Perneger, A F Junod, H Bounameaux, A Perrier.   

Abstract

OBJECTIVE: To develop a simple standardized clinical score to stratify emergency ward patients with clinically suspected pulmonary embolism (PE) into groups with a high, intermediate, or low probability of PE to improve and simplify the diagnostic approach.
METHODS: Analysis of a database of 1090 consecutive patients admitted to the emergency ward for suspected PE in whom diagnosis of PE was ruled in or out by a standard diagnostic algorithm. Logistic regression was used to predict clinical parameters associated with PE.
RESULTS: A total of 296 (27%) of 1090 patients were found to have PE. The optimal estimate of clinical probability was based on 8 variables: recent surgery, previous thromboembolic event, older age, hypocapnia, hypoxemia, tachycardia, band atelectasis, or elevation of a hemidiaphragm on chest x-ray film. A probability score was calculated by adding points assigned to these variables. A cutoff score of 4 best identified patients with low probability of PE. A total of 486 patients (49%) had a low clinical probability of PE (score </=4), of which 50 (10.3%) had a proven PE. The prevalence of PE was 38% in the 437 patients with an intermediate probability (score of 5-8; n = 437) and 81% in the 63 patients with a high probability (score >/=9).
CONCLUSIONS: This clinical score, based on easily available and objective variables, provides a standardized assessment of the clinical probability of PE. Applying this score to emergency ward patients suspected of having PE could allow a more effective diagnostic process.

Entities:  

Mesh:

Year:  2001        PMID: 11146703     DOI: 10.1001/archinte.161.1.92

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  67 in total

1.  Pulmonary embolism: investigation of the clinically assessed intermediate risk subgroup.

Authors:  D J Warren; S Matthews
Journal:  Br J Radiol       Date:  2011-09-21       Impact factor: 3.039

2.  British Thoracic Society guidelines for the management of suspected acute pulmonary embolism.

Authors: 
Journal:  Thorax       Date:  2003-06       Impact factor: 9.139

Review 3.  Acute pulmonary embolism. Part 1: epidemiology and diagnosis.

Authors:  Renée A Douma; Pieter W Kamphuisen; Harry R Büller
Journal:  Nat Rev Cardiol       Date:  2010-07-20       Impact factor: 32.419

4.  Reproduction of chest pain by palpation: diagnostic accuracy in suspected pulmonary embolism.

Authors:  Grégoire Le Gal; Ariane Testuz; Marc Righini; Henri Bounameaux; Arnaud Perrier
Journal:  BMJ       Date:  2005-01-31

5.  D-dimer for the diagnosis of acute venous thromboembolism in the emergency department: a Janus-face marker.

Authors:  Roberto Manfredini
Journal:  Intern Emerg Med       Date:  2006       Impact factor: 3.397

6.  Patients with an intermediate or high risk of a pulmonary embolism continue to pose a diagnostic challenge.

Authors:  D Grant; P Rosen
Journal:  Intern Emerg Med       Date:  2007-10-01       Impact factor: 3.397

Review 7.  Is the lung scan alive and well? Facts and controversies in defining the role of lung scintigraphy for the diagnosis of pulmonary embolism in the era of MDCT.

Authors:  John H Reid; Emmanuel E Coche; Tomio Inoue; Edmund E Kim; Maurizio Dondi; Naoyuki Watanabe; Giuliano Mariani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-01-27       Impact factor: 9.236

8.  Vena cava inferior thrombosis detected by venous hum: a case report.

Authors:  Robert Colebunders; Britt Colebunders
Journal:  J Med Case Rep       Date:  2007-08-22

9.  Usefulness of Clinical Prediction Rules, D-dimer, and Arterial Blood Gas Analysis to Predict Pulmonary Embolism in Cancer Patients.

Authors:  Asifa Karamat; Shazia Awan; Muhammad Ghazanfar Hussain; Fahad Al Hameed; Faheem Butt; Ali Saeed Wahla
Journal:  Oman Med J       Date:  2017-03

Review 10.  Diagnosis of pulmonary embolism.

Authors:  Clive Kearon
Journal:  CMAJ       Date:  2003-01-21       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.